Napoli Bern Ripka Law Firm
Napoli Bern Ripka, LLP Blog
September 24, 2009
In consultation with the Food and Drug Administration (FDA), McNeil Consumer Healthcare is voluntarily initiating a recall of certain lots of Children's and Infants' Tylenol® liquid products.
The product website www.tylenol.com states the recall is due to an unused portion of one inactive ingredient did not meet all quality standards, but a letter to healthcare professionals details the recall is attributed to a bacteria, Burkholderia cepacia (B. cepacia), detected in bulk raw material. Although the portion of raw material in which the bacteria was found was isolated and was not used in the production of any finished product, all product that utilized any of the raw material manufactured during that time period is recalled as a precaution. McNeil claims bacteria have not been detected in finished product and the finished product has met all specifications.
Ingestion of contaminated pharmaceutical product is not known to be a route of transmission of B. cepacia infection, but infection has been reported following the use of contaminated pharmaceutical products such as mouthwashes and nasal sprays. Adverse health consequences of B. cepacia infections could be potentially severe especially in high-risk patients, such as those with underlying pulmonary disease, cystic fibrosis or compromised immune systems.
McNeil Consumer Healthcare advises concerned parents and caregivers who have administered affected product to their child or infant to contact their healthcare providers or call McNeil's consumer call center at 1-800-962-5357.
The recalled products were manufactured between April 2008 and June 2008. Consumers can find the lot numbers on the bottom of the box containing the liquid product and on the sticker surrounding the product bottle. For recalled product description and lot number list, please click here: http://www.tylenol.com/generic.jhtml?id=tylenol/news/subpchildinfantnews.inc.
The recall does not apply to Children's TYLENOL® Meltaways and Junior Strength TYLENOL® Meltaways, which were the subject of a 2005 Food and Drug Administration (FDA) alert due to confusing packaging that could lead to children getting the wrong dose, including a possible overdose.
If your child, a child in your family or anyone you know have used any of these recalled Tylenol products and suffered adverse reactions as a result, please contact the attorneys here at Napoli Bern Ripka Law Firm LLP. Our law firm has helped so many people who have become victims of recalled medications. The consultation is free; just call 1-888-529-4669
Post a Comment to "Bacterial Contamination Prompts Recall of Children’s and Infants’ Tylenol"
To reply to this message, enter your reply in the box labeled "Message", enter your name and email, and hit "Post Message."
Napoli Bern LLP
350 5th Avenue
Suite 7413
New York, NY 10118
Toll Free: 877 WTC HERO
Phone: 212 267 3700
Napoli Bern LLP
350 5th Avenue, Suite 7413,
New York, NY 10118
Toll Free: 1 888 LAW IN NY
Phone: 212 267 3700
New York
350 5th Avenue,
Suite 7413,
New York, NY 10118
3500 Sunrise Highway,
Suite T-207
Great River, NY 11739
New Jersey
1 Greentree Centre
Suite 201
Marlton, NJ 08053
Pennsylvania
2 Penn Center, Suite 200
Philadelphia, PA 19102
Exposure to Hepatitis C Could Spark Lawsuits
New York Defective Drugs and Medical Devices Lawyers
New York Auto Accident Lawyers
New York Construction and Jobsite Accident Lawyers
FDA Drugs and Personal Injury Lawyer - Marc Bern
Marc Bern on CourtTV discussing Fen-Phen
Marc Bern discusses the Diet Drug FenPhen on Geraldo
Marc Bern is on Geraldo discussing the diet drug Fen-Phen
Trial Attorney Marc Bern discusses Breast Implants on Court TV
Nancy Grace with Marc Bern about Jenny Jones Trial